Skip to content
Collegium Pharmaceutical
Medical Affairs
Mobile Menu Toggle navigation
Collegium Pharmaceutical
Medical Affairs
  • Resources
    • Resources
    • Upcoming Meetings
  • Medical Information
  • Education
  • Request a Follow-Up
  • Keep Me Updated
  • Resources
    • Resources
    • Upcoming Meetings
  • Medical Information
  • Education
  • Request a Follow-Up
  • Keep Me Updated
Collegium Pharmaceutical
  • Resources
    • Resources
    • Upcoming Meetings
  • Medical Information
  • Education
  • Request a Follow-Up
  • Keep Me Updated

Larson SJ, Pestaner J, Prashar SK, Bayard C, Zarwell LW, Pierre-Louis M. Postmortem distribution of tapentadol and N-desmethyltapentadol. J Anal Toxicol. 2012;36(6):440-443. doi:10.1093/jat/bks041

Post navigation

Effectiveness and safety of tapentadol prolonged release with tapentadol immediate release on-demand for the management of severe, chronic osteoarthritis-related knee pain: results of an open-label, phase 3b study
Imputing at-work productivity loss using results of a randomized controlled trial comparing tapentadol extended release and oxycodone controlled release for osteoarthritis pain

Leave a Reply Cancel reply

You must be logged in to post a comment.

Collegium Pharmaceutical
  • info@collegiumpharma.com
  • (781) 713-3699
  • Privacy Policy
  • Terms of Use
  • Site Credits

© 2023